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ABSTRACT
In mammals, faithful inheritance of genomic methy-
lation patterns ensures proper gene regulation and
cell behaviour, impacting normal development and
fertility. Following establishment, genomic methyla-
tion patterns are transmitted through S-phase by the
maintenance methyltransferase Dnmt1. Using a pro-
tein interaction screen, we identify Microprocessor
component DROSHA as a novel DNMT1-interactor.
Drosha-deficient embryonic stem (ES) cells display
genomic hypomethylation that is not accounted for
by changes in the levels of DNMT proteins. DNMT1-
mediated methyltransferase activity is also reduced
in these cells. We identify two transcripts that are
specifically upregulated in Drosha- but not Dicer-
deficient ES cells. Regions within these transcripts
predicted to form stem–loop structures are pro-
cessed by Microprocessor and can inhibit DNMT1-
mediated methylation in vitro. Our results highlight
DROSHA as a novel regulator of mammalian DNA
methylation and we propose that DROSHA-mediated
processing of RNA is necessary to ensure full DNMT1
activity. This adds to the DROSHA repertoire of non-
miRNA dependent functions as well as implicating
RNA in regulating DNMT1 activity and correct levels
of genomic methylation.
INTRODUCTION
In mammals, methylation at CG dinucleotides is required
for the monoallelic expression of genes subject to genomic
imprinting, transcriptional silencing of retrotransposons
and X chromosome silencing in females (1). In animals,
genomic methylation patterns are initially established by
the de novo methyltransferases Dnmt3A and Dnmt3B (2)
following two stages of methylation loss that occurs prior
to implantation of the embryo (3) as well as during the
migration of primordial germ cells (PGCs) (4). Follow-
ing establishment, genomic methylation patterns are trans-
mitted through S-phase by the maintenance methyltrans-
ferase DNA methyltransferase 1 (DNMT1). Given the im-
portance of faithful inheritance of cytosinemethylation, un-
derstanding how DNMT1 is correctly regulated is crucial.
Normal DNMT1 function is achieved by a combination of
its correct targeting (5–7), control of protein stability (8,9)
and regulation of its methyltransferase activity (10). How-
ever, our understanding of the mechanisms involved and
how they interact remains incomplete.
RNA has long been proposed to regulate DNA methy-
lation (11). In the mammalian germ line, DNA methyla-
tion establishment depends on the biogenesis of a partic-
ular class of small RNAs termed piwi-interacting (piRNA)
in prospermatogonial stem cells (12,13), but the mechanism
linking these two processes remains unknown. Although
piRNAs are believed to instruct where DNMTs are tar-
geted, it is also possible that RNA may have a regulatory
function controlling methyltransferase activity. DNMT1-
interacting RNAs (DiRs) have recently been described (14)
that are postulated to inhibit DNMT1 catalytic activity
through their interaction with the C-terminal methyltrans-
ferase domain, although their general function and mecha-
nisms regulating them are unknown.
Using a protein interaction screen to further define the
mechanism by which DNMT1 is regulated, we identify the
Microprocessor component DROSHA as a novel DNMT1-
interactor. Using CRISPR/Cas gene editing to inactivate
Drosha in mouse embryonic stem (ES) cells, we show that
in its absence, genome-wide cytosine methylation is reduced
and thatDROSHArosha ensures full DNMT1methyltrans-
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ferase activity. We also present evidence demonstrating that
human DROSHA is capable of processing regions of pre-
viously identified DiRs, and that these inhibit DNMT1-
activity. Based on these results, we propose that DROSHA-
mediated processing of DiRs is necessary to ensure full
DNMT1 activity, adding to the DROSHA repertoire of
non-miRNA dependent functions.
MATERIALS AND METHODS
Embryonic stem (ES) cell culture
Mouse ES cells were cultured in ES cell media that con-
sisted of Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 15% fetal bovine serum (FBS), 100
IU/ml penicillin, 100 mg/ml streptomycin, 2 mmol/l L-
glutamine, MEM non-essential amino acids, 0.12 mmol/l
-mercaptoethanol and leukaemia inhibitory factor (LIF).
During the targeting process, ES cells were cultured on
mitomycin C-treated mouse embryonic fibroblasts (MEF)
feeder cells. For downstream analysis, ES cells were cultured
on gelatin-coated plates.
Protein identification by nano-liquid chromatography cou-
pled to tandem mass spectrometry (LC-MS/MS) analysis
Immunoaffinity-purified material from Dnmt1Tag/+ and
parental Dnmt1+/+ ES cells were resolved briefly, using
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE), followed by staining with Coomassie Blue
and excision of the separated protein bands. In situ trypsin
digestion of polypeptides in each gel slice was performed
as described (15). The tryptic peptides were purified us-
ing a 2 l bed volume of Poros 50 R2 (Applied Biosys-
tems, CA, USA) reversed-phase beads packed in Eppen-
dorf gel-loading tips. The purified peptides were diluted to
0.1% formic acid and then subjected to nano-liquid chro-
matography coupled to tandem mass spectrometry (nano-
LC-MS/MS) analysis as follows. Peptidemixtures (in 20l)
were loaded onto a trapping guard column (0.3× 5mmAc-
claim PepMap 100C18 cartridge fromLCPackings, Sunny-
vale, CA,USA) using anEksigent nanoMDLC system (Ek-
sigent Technologies, Inc. Dublin, CA, USA) at a flow rate
of 20 l/min. After washing, the flow was reversed through
the guard column and the peptides eluted with a 5–45% ace-
tonitrile gradient over 85 min at a flow rate of 200 nl/min,
onto and over a 75-× 15-cm fused silica capillary PepMap
100 C18 column (LC Packings, Sunnyvale, CA, USA). The
eluent was directed to a 75- (with 10- orifice) fused sil-
ica nano-electrospray needle (NewObjective,Woburn,MA,
USA). The electrospray ionization needle was set at 1800
V. A linear ion quadrupole trap-Orbitrap hybrid analyzer
(LTQ-Orbitrap, ThermoFisher, San Jose, CA, USA) was
operated in automatic, data-dependentMS/MSacquisition
mode with oneMS full scan (450–2000m/z) in the Orbitrap
analyzer at 60 000 mass resolution and up to 10 concurrent
MS/MS scans in the Linear TrapQuadropole (LTQ) for the
10 most intense peaks selected from each survey scan. Sur-
vey scans were acquired in profile mode and MS/MS scans
were acquired in centroid mode. The collision energy was
automatically adjusted in accordance with the experimental
mass (m/z) value of the precursor ions selected forMS/MS.
Minimum ion intensity of 2000 counts was required to trig-
ger an MS/MS spectrum; dynamic exclusion duration was
set at 60 s.
Initial protein/peptide identifications from the LC-
MS/MS data were performed using the Mascot search
engine (Matrix Science, version 2.5.0; www.matrixscience.
com) with the rodent segment of Uniprot protein database
(20 255 sequences; European Bioinformatics Institute,
Swiss Institute of Bioinformatics and Protein Information
Resource). The search parameters were as follows: (i) two
missed cleavage tryptic sites were allowed; (ii) precursor ion
mass tolerance = 10 ppm; (iii) fragment ion mass tolerance
= 0.8 Da; (iv) variable protein modifications were allowed
for methionine oxidation, deriving cysteine acrylamide and
protein N-terminal acetylation. MudPit scoring was typi-
cally applied using significance threshold score P < 0.01.
Decoy database search was always activated and, in general,
for merged LS-MS/MS analysis of a gel lane with P< 0.01,
false discovery rate averaged∼1%. Scaffold (Proteome Soft-
ware Inc., Portland, OR), version 4 4 5 was used to further
validate and cross-tabulate the MS/MS-based peptide and
protein identifications. Protein and peptide probability was
set at 95% with a minimum peptide requirement of 1.
Western blot
Pelleted cells were lysed in Radioimmunoprecipitation
(RIPA) buffer. Samples were quantified using Bio-Rad Pro-
tein Assay (Bio-Rad) and equal amounts of lysate were
loaded onto Mini-Protean Gels (Bio-Rad). Following sep-
aration by electrophoresis, proteins were transferred onto
nitrocellulose membrane (GE Healthcare), blocked in 1×
Phosphate Buffered Saline + 0.1% Tween-20 (PBST) + 5%
milk for 1 h before incubating with primary antibodies
overnight. The next day, membranes were washed in PBST,
incubated with secondary antibody, washed in PBST, be-
fore horseradish peroxidase (HRP) signal development us-
ing Luminata Forte Western HRP Substrate (Millipore).
Signals were detected by exposure of membranes onto Hy-
perfilm ECL (Amersham).
Antibodies
For western blot, the following antibodies were used at the
dilutions indicated:
Anti-FLAG (1:3000, F3165, Sigma-Aldrich); Anti-myc
(1:3000, 2276, CST); Anti-HA (1:750, 3724, CST); Anti-
Tubulin (1:20000, T6199, Sigma-Aldrich); Anti-Drosha
(1:2000, 3364, CST; 1,2000, SC393591, Santa Cruz Biotech-
nology; 1:2000, ab12286, abcam); Anti-Dnmt1 (1:2000,
5032, CST); Anti-Dnmt3A (1:3000, SC20703, Santa Cruz
Biotechnology); Anti-Dnmt3B (1:3000, SC52922, Santa
Cruz Biotechnology); Anti-Dnmt3L (1:1000, 12309, CST);
Anti-Uhrf1 (1:800, SC98817, Santa Cruz Biotechnol-
ogy); Anti-Histone H3 (1:2000, ab1791, abcam); Anti-Tet1
(1:1000, 09–872, Millipore); Anti-Tet2 (1:1000, ABE364,
Millipore); Donkey anti-rabbit HRP (1:5000, NA934V, GE
Healthcare); Sheep anti-mouse HRP (1:5000, NA931V, GE
Healthcare).
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MethylC-seq library preparation, sequencing and methyla-
tion level calculation
Libraries, analysis of sequencing data and calculation of
weighted methylation levels were as described in Vla-
chogiannis et al. (16).
RNA-seq library preparation
Total RNA was purified from ES cells using TRIzol
Reagent (ThermoFisher Scientific), before treating with
DNase Turbo (Ambion). RNA was then purified into
mRNA and short and long RNA using Oligotext mRNA
Mini Kit (Qiagen) and mirVana™ miRNA Isolation Kit
(ThermoFisher Scientific), respectively. ERCCRNA Spike-
In Mix (ThermoFisher Scientific) was added to all RNA
samples. Post-purification, short RNAs were treated with
Ribo-Zero (Illumina) to remove rRNA. Post purification,
mRNAs were fragmented by magnesium treatment fol-
lowed by phosphatase-mediated repair of cleaved ends us-
ing Antarctic Phosphatase (NEB) and T4 Polynucleotide
Kinase (PNK) (NEB). Following a final cleanup using
RNeasy Kit (Qiagen), sequencing libraries were generated
for both mRNA and short RNA fractions using NEBNext
Multiple Small RNA Library Prep Protocol (NEB). De-
pending on the starting amount of input RNA, between
10 and 12 cycles were used for amplification, followed by
size fractionation by gel electrophoresis. Amplicons in the
130–350 bp size range were gel-excised and purified us-
ing Mini-Elute Gel Extraction Kit (Qiagen), followed by
real-time PCR (qPCR)-based quantification usingKapaLi-
brary QuantificationKit (Kapa Biosystems) and analysis of
size distribution using a Bioanalyzer High Sensitivity DNA
Chip (Agilent). Samples were sequenced on a NextSeq 500
(Illumina).
Expression analysis of RNA-seq data
Adapter sequence was removed from fastq reads using
fastq-mcf (−S, −t 0.0001, −l 20). Reads were then trimmed
according to quality score using seqtk trimfq (−q 0.01)
and aligned to the mouse genome (mm10) with TopHat2
(v2.0.9, –b2-very-sensitive, −g 2, −p 4, –library-type fr-
secondstrand, default settings for –mate-inner-dist and –
mate-std-dev). Strand-specific bigWig files for visualization
of the data in the UCSC Genome Browser were generated
using only TopHat2 mapped reads with unique hits on the
genome using a custom pipeline incorporating Samtools to
select for strand-specific reads, the bedtools genomecov tool
and the bedGraphToBigWig tool from UCSC. Transcripts
were assembled for wild-type and Drosha−/− datasets re-
spectively for each of the RNA types (short, long and
mRNA) using Cufflinks v2.1.1, with default settings (−g
gencode.vM3.annotation.gtf). Wild-type transcripts were
then merged with Drosha−/− transcripts to obtain master
transcriptomes for each pairwise comparison of gene ex-
pression, in each RNA type, allowing differential gene ex-
pression to be assessed using cuffdiff. Differential expres-
sion analysis of Dnmt3 isoforms in the mRNA dataset was
performed as part of the Cufflinks pipeline, prior to differ-
ential gene expression analysis.
Accession number
The data generated for this study have been deposited in
the Gene Expression Omnibus (http://www.ncbi.nlm.nih.
gov/geo/) and are accessible through accession number
GSE86907.
Design of gRNA and CRISPR/Cas targeting
A suitable target of CRISPR sgRNA within the Drosha lo-
cus was identified according to the rules outlined in Mali
et al. (17). Briefly, the selected target sequence (5′-GCA
CCG AGA TCA CAG TCA C-3′) was incorporated into
a 455 bp fragment containing all the necessary components
for guide RNA (gRNA) expression (U6 promoter, gRNA
scaffold and termination signal) and synthesized as a gene
block (Integrated DNA Technologies, IDT). This gRNA
fragment was polymerase chain reaction (PCR) amplified
prior to use for transfection. In addition, a neo-replacement
cassette with 75 bp homology arms either side of the Cas9
cut site was synthesized by PCR amplification and included
for homology-dependent repair. On the day of transfection,
5 × 106 ES cells were seeded onto a 6 cm tissue culture
plate and allowed to attach for at least six hours. Cells were
transfected with PCR amplified gRNA, neo-replacement
cassette and hCas9 expressing plasmid (hCas9, 41815, Ad-
dgene) using Effectene transfection reagent (Qiagen) ac-
cording to the manufacturer’s protocol. A total of 15 g of
DNA was used per transfection. Cells were transfected for
up to 20 h, before re-plating at low density on gelatinized
15 cm tissue culture plates. Twenty-four hours after seed-
ing, cells were placed under selection by the addition of
G418 (300 g/ml) to the culture media. After 6–10 days,
individual colonies were picked and expanded. For addi-
tional Drosha-deficient clones, the following modifications
were made. The neo-replacement cassette was omitted and
transfected DNA included a puromycin-resistance plasmid
(pSUPER.retro.puro, Oligoengine). Twenty-four hours af-
ter seeding, cells were placed under puromycin selection for
48 h before replacing with and further culturing in drug-free
ES cell media.
Screening for Drosha-deficiency
PCR primers outside of the homology arms of the replace-
ment cassette were designed and used to detect clones that
had undergone homology-dependent repair and insertion
of the selection cassette. 5′ and 3′ junctions were analysed by
PCR followed by Sanger sequencing. Candidate clones were
analysed by western blot using Drosha antibody to confirm
absence of the protein.
Generation of DROSHA expression construct
Mouse Drosha (AK148640/7120429A12) complementary
DNA (cDNA) was obtained from Source BioScience. PCR
primers were designed to amplify up full-length mouse
Drosha before cloning into the multiple cloning site of
pEGFP-C1 expression vector (Clonetech) and pcDNA3-
HA (ThermoFisher Scientific). Fragments corresponding
to different regions of mouse DROSHA were designed and
Downloaded from https://academic.oup.com/nar/article-abstract/45/16/9398/4064209/A-novel-requirement-for-DROSHA-in-maintenance-of
by University College London user
on 29 September 2017
Nucleic Acids Research, 2017, Vol. 45, No. 16 9401
generated by PCR using full-length Drosha cDNA accord-
ing to previously published human fragments (18). For frag-
ments 2, 3 and 4 that lack the endogenous DROSHA NLS,
the SV40 large T antigen NLS (PKKKRKVEDP) was in-
serted in-frame and downstream of the HA epitope in the
pcDNA3-HA cloning vector. ForDROSHAE1045Qmuta-
tion, site-directed mutagenesis was performed on pcDNA3-
HA containing wild-type full-length Drosha cDNA using
Q5® Site Directed Mutagenesis Kit (NEB). Sanger se-
quencing verified that all constructs were of correct se-
quence.
Immunoprecipitation
For FLAG immunoprecipitation of protein from
Dnmt1Tag/+ cells, two methods were used. For mass
spectrometry analysis, harvested cells were washed
twice in cold 1× Dulbecco’s PBS before re-suspending
in a hypotonic buffer (10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.65, 10
mM MgCl2, 10 mM KCl, 0.5 mM Dithiothreitol (DTT),
1× ethylenediaminetetraacetic acid (EDTA)-free Pro-
tease Inhibitor (Roche)). Cells were lysed by Dounce
homogenization. The cytosolic fraction was separated by
centrifugation at 4◦C (228 rcf, 10 min). The remaining
nuclear fraction was washed three times with Buffer N
(15 mM HEPES, pH 7.65, 10 mM MgCl2, 0.5 mM DTT,
250 mM sucrose, 1× EDTA-free Protease Inhibitor).
Nuclei were then re-suspended in a high salt buffer (5
mM HEPES, pH 7.65, 25% glycerol, 10 mM MgCl2, 0.2
mM EDTA, 0.5 mM DTT, 250 mM NaCl, 1× EDTA-free
Protease Inhibitor), with the NaCl concentration increased
to 300 mM by drop-wise addition of 5 M NaCl. Nuclei
were lysed in the presence of 75U of Universal Nuclease
(Pierce) by incubation at 4◦C for 2 h with agitation before
centrifugation at 4◦C (12 000 rcf, 20 min) to separate out
the soluble and insoluble/chromatin nuclear fractions.
FLAG-tagged Dnmt1 protein was immunoprecipitated
using anti-FLAG® M2 Magnetic Beads (Sigma-Aldrich)
according to the manufacturer’s protocol and eluted with
FLAG peptide (100 ng/ml, Sigma-Aldrich).
For co-immunoprecipitation followed by western blot,
ES cells lysates were prepared by harvesting cells and lysing
at a concentration of 2 × 107 cells/ml in Lysis Wash Buffer
(20 mM Tris–HCl, pH 7.4, 200 mMNaCl, 2.5 mMMgCl2,
0.05% Tween-20) supplemented with Protease Inhibitor
Cocktail (Roche). Cells were lysed using a microtipped
Misonix Sonicator 3000 (Misonix) (Output 1, 9 pulses for
15 s with 10-s recovery periods). Post-sonication, samples
were clarified by centrifugation (10 000 rcf, 10 min, 4◦C)
before incubating with anti-FLAG® M2 Magnetic Beads
as described above. Post-immunoprecipitation, beads were
washed and bound material released by incubation in SDS-
Page Sample Buffer at 95◦C for 10 min. Samples were elec-
trophoresed on 4–15% gradient SDS-PAGE acrylamide gel.
Immunofluorescence
COS-7 or NIH/3T3 cells were grown on coverslips and co-
transfected with DsRed-DNMT1 (human) (19) and HA-
DROSHA (mouse) expression constructs using FugeneHD
reagent (Promega) according to the manufacturer’s proto-
col for 48 h. Cells were then fixed with 1% paraformalde-
hyde. DsRed-DNMT1was visualized by excitationwith 561
nmwavelength, whilst DROSHA detection was by anti-HA
antibody (2367, CST) visualizedwith secondary anti-mouse
Alexa Fluor 488 dye (Molecular Probes). Images were ac-
quired on a Zeiss Confocal LSM 880 using Airyscan mode
(Zeiss). For quantification of DNMT1 and DROSHA co-
localization, Manders split coefficients were determined us-
ing the ImageJ JACoP plugin (ImageJ.net). Coefficients rep-
resent the number of red spots (DNMT1) coinciding with
green spots (DROSHA) with a threshold set at 0.4 for co-
localization in individual cells.
Measurement of genomic 5mC levels by LC-MS/MS
One microgram of genomic DNA was denatured at 98◦C
for 3 min, incubated on ice for 3 min and digested to sin-
gle nucleosides using 1 ml of a proprietary blend of nu-
cleases and phosphatases (New England Biolabs) at 37◦C
overnight. Post digestion, nucleosides were purified using a
QIAquick spin column (QIAgen). LC-MS analysis was per-
formed on an Agilent 1200 series HPLC system equipped
with a G1316A UV detector and 6120 mass detector (Agi-
lent, Santa Clara, CA, USA) with aWaters Atlantis T3 col-
umn (4.6 × 150 mm, 3 m, Waters (Milford, MA, USA))
equipped with an in-line filter and guard column. Peak
quantification was based on the integration area of each
target nucleoside at the maximum absorption of ultravio-
let (UV) and adjusted by its respective extinction coefficient
constant.
In vitro methyltransferase assay
ES cells were lysed and 10 g of crude cell extract was incu-
bated with 100 ng of hemi-methylated DNA in the presence
of 1 g RNase A for 30 min. Samples were transferred onto
filter discs and a liquid scintillation counter used to mea-
sure [3H]-CH3 incorporation into DNA. Two separate mea-
surements were taken for each sample. For humanDNMT1
methyltransferase assays in the presence of hairpin RNAs,
10 nM of purified, recombinant DNMT1 was mixed with
10 nM of in vitro transcribed and purified RNA and 5 mM
of 3[H]-SAM and 40 nM of hemi-methylated substrate in
methylase buffer.
In vitro transcription of RNA
For in vitro human DROSHA processing assays, gBlocks
(IDT) corresponding to the hairpins indicated were synthe-
sised with the inclusion of a T7 promoter sequence. gBlocks
were used for in vitro transcription according to the protocol
published by Lee and Kim (20). For in vitro transcription
followed by incubation with recombinant DNMT1, RNA
was synthesized using the same gBlocks and MEGAscript
T7 Transcription Kit (Thermo FisherScientific), according
to the manufacturer’s protocol.
In vitro RNA processing assay by DROSHA
In vitro transcribed RNAs were processed according to the
protocol described by Lee and Kim (20).
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Identification of RNA hairpins
Putative hairpins were identified using mFold web server
(21).
Retroviral transduction of Drosha-deficient ES cells
MouseDrosha cDNAwas cloned into pMSCV-puro (Clon-
tech), sequenced, verified and transfected into Phoenix
packaging cells. Briefly, on the day of transfection, 1 × 106
cells were seeded onto 10 cm tissue culture plates and left
for 4–5 h to attach. Cells were transfected overnight with
10–14 g of plasmid using Profection® reagent (Promega),
according to the manufacturer’s protocol. The next day,
culture medium was replaced with fresh ES cell medium.
Forty-eight and seventy-two hours after initial transfec-
tion, retroviral particle-containing medium was harvested
and syringe-filtered through a 0.45- membrane. Virus-
containing medium was mixed with polybrene (Sigma-
Aldrich) and used to transduce ES cells overnight. ES cells
were seeded on the day of transduction (4 × 106 onto a 10
cm tissue culture plate per transduction) and allowed to at-
tach for at least 5 h. The next day, medium was replaced
with fresh virus-containing medium and left overnight.
The following day, medium was replaced with puromycin-
containing ES cell medium (2 g/ml) and cultured for 6–
8 days. Puromycin-resistant colonies were picked and ex-
panded. DROSHA expression was determined by western
blot.
Primers
Sequences of PCRprimers used are listed in Supplementary
Table S3.
RESULTS
Drosha interacts with Dnmt1
To identify novel factors involved in correct mainte-
nance methylation, we generated ES cells expressing an
epitope-tagged version of the maintenance methyltrans-
ferase DNMT1 for use in a protein interaction screen. A
dual FLAG-c-myc tag was introduced after the start me-
thionine by homologous recombination in ES cells (Sup-
plementary Figure S1A). Following confirmation of correct
targeting at the endogenous locus (Supplementary Figure
S1B), and Cre-mediated removal of the floxed neo-selection
cassette, western blot using both anti-FLAGand anti-c-myc
antibodies confirmed the presence of signal at the expected
size in the targeted cell lines only (Supplementary Figure
S1C). This cell line is hereafter referred to as Dnmt1Tag/+.
The FLAG-epitope was subsequently used for native im-
munoprecipitation of tagged bait and associating proteins.
Nano-LC-MS/MS analysis of these interacting proteins
isolated from Dnmt1Tag/+ cells conclusively identified the
Class 2 RNase III enzyme DROSHA (Supplementary Fig-
ure S2A and Table 1). In addition, we detected peptides
that identified proteins corresponding to known DNMT1
and DROSHA interactors (UHRF11 and PCNA and
DGCR8, respectively). Together with the double stranded
RNA-binding protein DGCR8, DROSHA forms Micro-
processor complex, which processes long primary miRNAs
(pri-miRNAs) into short hairpin precursor miRNAs (pre-
miRNAs). As well as this canonical function in miRNA
biogenesis, DROSHA has also been shown to process
longer RNA species that contain stem–loop structures that
is necessary for correct, non-miRNA-mediated gene regula-
tion (22–25). We validated DROSHA interaction by west-
ern blot using anti-DROSHA antibody on FLAG immuno-
precipitated material from Dnmt1Tag/+ cells (Figure 1A).
In addition, FLAG immunoprecipitation on material from
DroshaTag/Tag ES cells followed by western blot revealed co-
immunoprecipitation with DNMT1 protein (Supplemen-
tary Figure S2B), further validating the interaction. To en-
sure that the DNMT1–DROSHA interaction was not due
to the presence of either FLAG or c-myc epitopes, we
performed FLAG-immunoprecipitation using Uhrf1Tag/+
and Dnmt3BTag/+ ES cells. Drosha was only found to co-
immunoprecipitate when purifying for DNMT1 (Supple-
mentary Figure S2C). Interestingly, we were able to co-
immunoprecipitate DROSHA with DNMT1 in nuclear ex-
tracts prepared from Dnmt1Tag/+ ES cells using an engi-
neered universal nuclease, which digested both DNA and
RNA (Supplementary Figure S2D). This suggests that the
interaction does not require either nucleic acid to be intact.
We next asked whether DNMT1–DROSHA interac-
tion was specific to pluripotent stem cells. Immunofluores-
cence analyses of COS-7 cells co-transfected with DsRed-
DNMT1 (human) andHA-DROSHA (mouse) revealed co-
localization of both proteins specifically in S-phase at punc-
tate foci (Figure 1B). The maintenance methylation ac-
tivity of DNMT1 is known to occur at hemi-methylated
DNA following replication. To determine the region(s) of
DROSHA required for DNMT1 interaction, we performed
co-localization analysis using expression constructs con-
taining different DROSHA domains (Figure 1C and Sup-
plementary Figure S3). Transient transfection in a differ-
ent cell line (NIH/3T3) again revealed co-localization of
DNMT1 and various DROSHA fragments during S-phase
(Figure 1D and E; Supplementary Figure S4). However,
there was a reduction in the percentage of cells showing co-
localization using Fragment 5, which lacks the majority of
the RNase catalytic domain, suggesting that the DROSHA
C-terminus is required for co-localization with DNMT1.
Interestingly, co-transfection of full-length DROSHA with
an expression construct encompassing the N-terminus of
DNMT1 (amino acids 2–452) showed similar levels of co-
localization to that observed using full-length DNMT1 in-
dicating that the N-terminus of DNMT1 is sufficient for
co-localization with DROSHA (Figure 1D and E). Co-
localization of DROSHA with DNMT1 was not signifi-
cantly affected in cells transfected with full-length Drosha
cDNA carrying a point mutation previously shown to
disrupt RNA-processing activity (E1045Q mutation). To-
gether, these results demonstrate DROSHA–DNMT1 in-
teraction, that it is not confined to pluripotent stem cells
and that it exists in native nuclear extracts under conditions
of both normal expression and transient overexpression.
Generation of Drosha-deficient ES cells
The existence of a DNMT1–DROSHA interaction sug-
gested that DROSHA might be required to ensure cor-
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Figure 1. Drosha interacts and co-localizes with Dnmt1. (A) Western blot using anti-Drosha antibody following immunoprecipitation with anti-FLAG
M2 magnetic beads on material from wild-type (+/+) and Dnmt1Tag/+ (Tag/+) ES cells. (B) Immunofluorescence micrographs of COS-7 monkey kidney
cells co-transfected with DsRed-DNMT1 and HA-Drosha constructs. (C) Cartoon showing different fragments of Drosha examined and the domains they
encompass. (D) Scatter plot showing distribution of cells with different Manders Split Coefficient values corresponding to co-localization between DsRed-
DNMT1 and the different HA-Drosha constructs indicated. ‘–’ indicates cells transfected with DsRed-DNMT1 only. Dnmt1N terminal fragment contains
amino acids 2–452. Exact Mann–Whitney P-values of different fragments compared to distribution using full-length HA-Drosha are Fr1 (0.0201), Fr2
(0.2872), Fr3 (0.3934), Fr4 (0.4197), Fr5 (0.0001), Fr6 (0.3403), DNMT1 N-term (0.1636) and Drosha E1045Q (0.211). (E) Bar graph showing percentage
of cells analysed with Manders Split Coefficient values of >0.4. Images from at least 50 cells were analysed per construct.
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Table 1. Selected list of peptides identified in anti-FLAG immunoprecipitated eluate from Dnmt1Tag/+ ES cells
Protein ID Molecular weight (kDa) Exclusive peptide spectrum matches Unique peptide spectrum matches Percent Seq. coverage (%)
Repeat 1 Repeat 2 Repeat 1 Repeat 2 Repeat 1 Repeat 2
DNMT1 183 586 770 139 160 78 81
UHRF1 88 18 15 14 11 29 19
PCNA 29 0 15 0 8 0 39
DGCR8 86 4 13 4 8 9.2 16
DROSHA 159 7 20 6 13 5.5 12
rect DNA methylation. To examine DROSHA function,
CRISPR/Cas technology was used to generate Drosha-
deficient ES cells (Figure 2A). PCR and sequencing anal-
ysis revealed one clone (F10) that carried two different
mutations; one mutant allele contained most of the neo-
replacement cassette whilst the other allele contained part
of the pgk promoter inserted in inverse orientation (summa-
rized in Figure 2A and B; Supplementary Figure S5). These
cells are hereafter referred to asDrosha−/−. Directed Sanger
sequencing also indicated the absence of exonic off-target
mutations (Supplementary Figure S6). Western blot data
confirmed the absence of detectable full-length DROSHA
protein using several antibodies raised against different re-
gions of the protein (Figure 2C). To confirm that these cells
were functionally deficient in miRNA biosynthesis, we per-
formed RNA-seq on short RNA libraries generated from
Drosha−/− ES cells. Examination of miRNAs revealed the
absence or reduction of 151 (93%) different miRNAs (Fig-
ure 2D and E, P = 4.182 × 10−10, Wilcoxon-rank sum test
and Supplementary Table S1). Interestingly, a small per-
centage of miRNAs is also found to be either unchanged
(5%) or elevated (7%) in Drosha−/− ES cells. We note that
the expression of three of these, Mir5099, Mir6240 and
Mir320, have previously been reported to be independent
of Dgcr8 in ES cells, indicating that they are not dependent
on Microprocessor activity for their biogenesis (26).
Previous studies on ES cells deficient for the other com-
ponent of Microprocessor Dgcr8 indicate that cells unable
to generate primiRNAs form smaller colonies in culture and
show defects in cell proliferation (27,28). We found that fol-
lowing seeding at the same density and passage duration in
culture, Drosha-deficient ES cells formed smaller colonies
compared to parental wild-type cells (Supplementary Fig-
ure S7A). Analysis of RNA-seq data indicated that in gen-
eral, Drosha-deficiency resulted in an increase in markers
associated with both naı¨ve and general pluripotency (Sup-
plementary Figure S7B). Cell cycle and viability analy-
sis revealed that as well as reduced proliferation, Drosha-
deficiency also resulted in increased apoptosis (Supplemen-
tary Figure S7C andD). Together, these results confirm pre-
vious data indicating that primiRNA processing is neces-
sary for normal ES cell function.
Drosha-deficiency results in reduced cytosine methylation
We next examined DNA methylation levels in Drosha−/−
ES cells. LC-MS/MS analysis of 5-methyl-cytosine (5mC)
levels of genomic DNA indicated this was significantly re-
duced in Drosha−/− cells (Figure 3A, P = 0.0007), a find-
ing supported by 5mC–DNA ELISA (Supplementary Fig-
ure S8A). To exclude the possibility that this observed hy-
pomethylation was due to normal clonal variation, we re-
targeted ES cells by CRISPR/Cas using the same gRNA
as previously described and generated an additional six in-
dependently derived clones deficient for Drosha. MiSeq-
sequence analysis confirmed mutation at the Drosha lo-
cus (Supplementary Figure S8B) and western blotting for
DROSHA protein confirmed absence of expression (Sup-
plementary Figure S8C). In all cases, genomic 5mC levels
were reduced compared to the parental cell line. Methyla-
tion levels dropped from 4.36% (129/SvEv) to as low as
3.31% (Clone A5) (Figure 3B). The current mouse reference
genome contains 4.37 × 107 mapped CG sites and based
on results from our whole genome bisulphite sequencing
(WGBS) data (see below), indicating that 64% of cytosines
in a CG context are methylated, this implies an absence
of methylation at between 157 000 (Clone A7) to over 350
000 CG sites (Clone A5) in Drosha-deficient cells. As the
mouse reference genome does not include CG-rich tandem
repeated sequences such as satellites, this range is likely
a conservative estimate. We also tested the direct require-
ment for DROSHA in regulating correct levels of DNA
methylation by using retroviral transduction to re-introduce
Drosha cDNA into Drosha−/− cells (Supplementary Fig-
ure S8D). This resulted in a recovery in levels of 5mC in
two independently transduced clones (Figure 3C). To test
the requirement for DROSHA catalytic activity in rescu-
ing genomic hypomethylation, we also transduced Drosha-
deficient ES cells with Drosha cDNA carrying a point mu-
tation previously shown to disrupt RNA-processing activ-
ity (E1045Q mutation, (18)). Surprisingly, despite express-
ing DROSHA protein at lower than endogenous levels ob-
served in wild-type ES cells, these cells actually displayed
greater hypomethylation than that observed in the parental,
Drosha-deficient line (Supplementary Figure S9A and B).
This could be due to clonal variation; we note that other in-
dependently targetedDrosha−/− ES cells display a range of
hypomethylation compared to wild-type cells (Figure 3B).
In ES cells, cytosine methylation occurs in both CG and
non-CG contexts, the latter of which is thought to be medi-
ated by de novo methyltransferases. Analysis of our WGBS
data revealed reductions in non-CG methylation (Supple-
mentary Figure S10A), consistent with the reduction in
5mC observed by LC-MS/MS. Interestingly, we were un-
able to detect any interaction between Dnmt3 family mem-
bers and Drosha (Supplementary Figure S10B). These re-
sults therefore indicate that Drosha is required to ensure
normal levels of genomic cytosine methylation.
CG methylation is reduced in all genomic compartments in
Drosha-deficient cells
The reduced methylation observed led us to investigate
whether this was a general genome-wide effect or confined
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Figure 2. Generation and characterization of Drosha-deficient ES cells. (A) CRISPR/Cas-mediated gene targeting strategy used to inactivate endogenous
Drosha locus. gRNA sequence is shown with hCas9 cut site highlighted in red. PCR primers used for screening are indicated by arrows (A,-E). Alleles
generated in Drosha−/− ES cells following CRISPR/Cas-mediated gene editing. Actual sequence of alleles is shown in Supplementary Figure S3. (B)
Agarose gel electrophoresis of PCR amplicons used to diagnose targeting ofDrosha locus. Primers are indicated in (A). (C) Western blot using anti-Drosha
antibodies recognizing different regions of DROSHA protein on whole cell extracts from wild-type and Drosha−/− ES cells. Anti-tubulin antibody used
as a loading control. Note that the lower band observed using the N-terminal antibody is a non-specific signal. (D) Box-whisker plots of RNA-seq data
from wild-type and Drosha−/− small RNA libraries. P = 4.182 × 10−10 (Wilcoxon-rank sum test). Expression levels (log2 fragments per kb of exon per
million fragments (fpkm)) of 162 miRNAs. (E) Pie chart indicating percentage of miRNAs in different categories caused by Drosha-deficiency.
to specific genomic compartments. To examine CG methy-
lation at base resolution in an unbiased manner, we per-
formed WGBS on DNA from wild-type, Drosha−/− and
Dnmt1-deficient (Dnmt1c/c) ES cells. Analysis of the distri-
bution of methylation levels of each cytosine in CG context
indicated a reduction in Drosha−/− cells compared to wild-
type (Figure 3D), consistent with our analysis bymass spec-
trometry. We observed reduced methylation in various se-
quence compartments analysed (Figure 3E and Supplemen-
tary Figure S11A; P < 2.2 × 10−16 for all compartments).
Analysis of a number of differentmethylation target regions
by Bisulphite Amplicon Sequencing (BSAS) recapitulated
our WGBS data as well as revealing that re-introduction of
Drosha into Drosha-deficient ES cells resulted in the recov-
ery of DNA methylation (Supplementary Figure S11B and
Table S2). We note that the Airn/Igf2r DMR is largely un-
methylated in wild-type ES cells and the recovery at this loci
in Drosha-complemented cells was less than that observed
in the other regions analysed. We also examined methyla-
tion levels within gene bodies to determine if there was any
correlation between gene expression differences observed
and the level of CGmethylation. Although we observed hy-
pomethylation in gene bodies in Drosha-deficient ES cells,
this did not correlate with expression. Gene body methy-
lation was reduced to the same degree in both highly and
lowly expressed genes, as well at 15 000 randomly sampled
RefSeq genes (Figure 3F).We conclude that the hypomethy-
lation observed is genome-wide, consistent with a general
defect in the methylation machinery.
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Figure 3. Drosha-deficiency results in global hypomethylation. (A) Bar graphs showing LC-MS/MS results measuring percentage of 5mC in genomicDNA
extracted from wild-type (+/+) and Drosha-deficient (−/−) ES cells. Exact P-value = 0.0007 (Mann–Whitney test). (B) Same as (A) but measurements
made on genomic DNA extracted from wild-type and various Drosha-deficient ES cell clones. (C) Same as (A) but measurements made on genomic
DNA extracted from wild-type, Drosha-deficient ES cells and two independently transduced clones of Drosha-deficient ES cells expressing Drosha cDNA
(+Drosha cDNA). (D) Box-whisker plots showing the distribution ofmethylation levels of each cytosine in CG context represented inWGBS data generated
from the cell lines indicated. (E) Notched box-whisker plots showing weighted CGmethylation levels in the various compartments in the different cell lines
indicated; c/c indicates Dnmt1c/c, which are deficient for DNMT1 protein. Exact P-values (Wilcoxon-rank sum test) for comparisons between wild-type
and Drosha−/− are P < 2.2 × 10−16. (F) Metaplots of CG methylation within gene bodies for 15 000 randomly selected RefSeq genes, genes up- and
downregulated inDrosha−/− compared to wild-type ES cells. Deregulated genes defined as those with a>1.5-fold change and P-value< 0.05 inDrosha−/−
mRNA-Seq dataset compared to wild-type. All bar graphs show mean +/− standard deviation.
Analysis of components involved in regulating DNAmethyla-
tion
A number of groups have independently derived Dicer-
deficient ES cells and these have demonstrated the role of
miRNAs in regulating levels of DNMTs. Although not all
are in agreement on the effect or precise mechanism, these
studies have consistently reported that Dicer-deficient ES
cells have reduced expression of DNMT3A and DNMT3B
(29–31). Analysis of global DNA methylation levels in
Dicer-deficient ES cells by LC-MS/MS revealed that these
are normally methylated, arguing against a general role for
miRNA biogenesis in controlling DNA methylation (Sup-
plementaryFigure S12). To determinewhether the observed
hypomethylation was a consequence of reduced expression
of DNMTs and known adaptor proteins, we performed
western blot analysis. This revealed that steady-state pro-
tein levels were unchanged, although there was a trend to-
wards increased expression of DNMT3A and DNMT3B in
Drosha−/− cells (Figure 4A). Analysis of RNA-seq data in-
dicated thatDnmt1, 3A and 3B transcript levels were higher
inDrosha−/− cells, althoughDnmt3LmRNA levels were re-
duced (Figure 4B). Analysis of quantitative real-time PCR
(qRT-PCR) data revealed that levels ofDnmt1 andDnmt3B
were modestly, but significantly elevated (Figure 4C). In
particular, Dnmt3A levels showed more than a 3-fold in-
crease in expression whilst levels ofUhrf1 andDnmt3Lwere
reduced. Together, these data indicate that expression lev-
els of DNMT proteins are their adaptors are unchanged in
Drosha−/− cells.
Recent reports suggest that DNMT3B isoforms lacking
catalytic activity are capable of stimulating other catalytic
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Figure 4. Analysis of components involved in regulating DNA methylation (A). Western blot data using the various antibodies indicated on nu-
clear extracts from the ES cell lines indicated. Triple Knockout (TKO) is an ES cell line deficient for all three active DNA methyltransferases
(Dnmt1−/−Dnmt3A−/−Dnmt3B−/−). (B) Bar graph of RNA-seq data showing expression levels of genes indicated. (C) Bar graphs of qRT-PCR data
showing expression levels of the factors indicated. Results representative of three biological replicates. For Uhrf1 levels, exact P-value = 0.0571 (Mann–
Whitney test). For all other genes, P = 0.028. Gapdh used for normalization. (D) RNA-Seq data traces for Dnmt3A and Dnmt3B loci. (E) Bar graphs of
RNA-seq data of differentDnmt3 isoforms indicated. (F) Same as (E), but showing Image-J quantified protein levels. (G) Western blot data using anti-Tet1
and Tet2 antibody. Anti-tubulin used as loading control.
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isoforms/partners (32). We therefore considered if the hy-
pomethylationwe observed could be attributed to perturba-
tions in the expression of these regulatory isoforms. We re-
analysed our mRNA-seq data to determine expression lev-
els of the various known, translated Dnmt3A and Dnmt3B
isoforms (Figure 4D and E). mRNA levels of Dnmt3A1
and Dnmt3A2 were both elevated in Drosha-deficient ES
cells. The predominant Dnmt3B isoforms detected were
Dnmt3B1/5 and Dnmt3B6/4, which are catalytically active
and inactive, respectively. Both isoforms were elevated in
Drosha-deficient ES cells, although this increase was higher
for the catalytically active compared to the inactive iso-
forms. Quantification of protein levels of different Dnmt3
isoforms recapitulated the RNA-seq data, althoughwe note
that levels of the catalytically inactive DNMT3B6/4 iso-
forms were reduced (Figure 4F). In general, these data sug-
gest that Drosha-deficiency results in an increase in all cat-
alytically active DNMT3 isoforms and that alterations in
the levels of catalytically active compared to inactive iso-
forms are unlikely to account for the genomic hypomethy-
lation observed.
TET proteins are capable of oxidizing 5mC to 5hmC and
other derivatives and are considered to play a role in both
active and passive loss of DNA methylation (33). To ex-
amine whether changes in TET expression levels could ac-
count for the global hypomethylation observed in Drosha-
deficient ES cells, we examined the expression levels of both
TET1 and TET2, the two predominant Tet enzymes ex-
pressed in ES cells by western blot (Figure 4G). This re-
vealed that while TET1 levels are comparable between wild-
type and Drosha-deficient cells, TET2 levels are actually re-
duced.
Following methyl extraction by DNMT1, the methyl-
donor S-adenosylmethionine (SAM) (used in the methy-
lation of all biological substrates) is converted into S-
adenosylhomocysteine (SAH), which has previously been
shown to inhibit DNMTactivity. To determine whether dis-
turbances in the ratio of SAM and SAH might contribute
to the hypomethylation observed, we firstly analysed our
RNA-seq data to determine if there were any reductions
in the expression of enzymes involved in SAM metabolism
(Supplemental Figure S13A). This revealed that while ex-
pression of cystathionine-beta-synthase (Cbs) was reduced
in Drosha-deficient cells, expression of the other key com-
ponents involved in SAMmetabolismwas actually elevated.
Furthermore, analysis of the ratio of SAM compared to
SAH in cell extracts fromDrosha-deficient cells by enzyme-
linked immunosorbent assay (ELISA) revealed no signif-
icant difference (Supplementary Figure S13B, P-value >
0.9999, Mann–Whitney test). These data indicate that de-
fects in SAM–SAHmetabolism are unlikely to be responsi-
ble for the hypomethylation observed.
Together, these data reveal functional differences between
DROSHA and DICER in their regulation of DNMT ex-
pression and they suggest that the hypomethylation ob-
served is unlikely to be accounted for by reduced protein lev-
els of the various DNMTs and their adaptors or increased
expression of TET1 and TET2.
DNMT1 methyltransferase activity is reduced by Drosha-
deficiency
In light of our findings that DNMT protein levels were
not reduced in Drosha−/-cells, the genomic hypomethyla-
tion observed was unexpected. In addition, we failed to
detect any conspicuous perturbation in DNMT1 localiza-
tion in Drosha-deficient ES cells (Supplementary Figure
S13), arguing against any gross alterations in DNMT1 sub-
cellular localization. We therefore posited whether absence
of DROSHA had any effect on DNMT1 activity. Using
an in vitro methyltransferase assay, we examined whether
DNMT1 methyltransferase activity on hemi-methylated
DNA, the preferred substrate for this enzyme (34), was
altered in Drosha-deficient ES cells. Cell extracts from
Drosha−/− ES cells consistently harboured reduced methyl-
transferase activity compared to extracts from parental
wild-type ES cells (Figure 5A, P = 0.022, Mann–Whitney
test). These data indicate that the presence of Drosha has a
stimulatory role on DNMT1-mediated DNA methylation.
DNMT1-interacting RNAs are upregulated in Drosha-
deficient cells
Given that the hypomethylation observed in Drosha-
deficient ES cells occurs without any reduction in the
expression of proteins known to impact DNA methyla-
tion and that genetically Drosha is necessary to stimulate
DNMT1 activity, we considered alternative mechanisms to
account for our observations. A number of recent studies
indicate the ability of RNA to interfere with DNMT1 cat-
alytic activity. In particular, DiRs have recently been re-
ported and proposed to inhibit catalytic activity (14). We
therefore wondered if any of the transcripts reported to in-
hibitDNMT1 activity are also specific targets ofDROSHA.
To eliminate genes that are targets of miRNA regulation
and therefore may not be direct targets for DROSHA,
we cross-referenced our transcriptome data from Drosha-
deficient ES cells with a list of genes shown previously to
be upregulated inDicer-deficient ES cells (29) prior to com-
paring this to a list of 3632 DiRs. This resulted in a list of
10 candidate genes (Figure 5B). qRT-PCR was then used
to verify the expression status of these genes with the in-
clusion of RNA from Dicer-deficient ES cells (Figure 5C).
As controls, we examined expression of two loci known to
generate RNA that is directly cleaved by DROSHA. These
were the mRNA Dgcr8 that generates the other compo-
nent of Microprocessor complex and the long non-coding
RNA (lncRNA) Mir17hg/miR-17∼92. Of the genes anal-
ysed, two, Fbxo15 and Cd97, were found to be consistently
upregulated specifically in Drosha−/− ES cells. We also ob-
served upregulation of these genes in the other Drosha-
deficient cell lines generated (Supplementary Figure S15,
P = 0.0286). These data demonstrate the identification of
two transcripts that are specifically upregulated in Drosha-
deficient ES cells, which have also been previously identified
as DiRs.
DROSHA has been shown to process non-miRNA tar-
gets at hairpin/stem loop structures (22,35). Using sec-
ondary structure prediction software (mFOLD) (21), we
identified several putative hairpin regions in Fbxo15 and
Cd97 (Figure 5D). Using an in vitro Microprocessor RNA
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Figure 5. DROSHA upregulated RNAs are processed byMicroprocessor and inhibit DNMT1-mediated methyltransferase activity. (A) Bar graph showing
3H-labelled SAM incorporation into hemi-methylated DNA by lysate from ES cells with the genotypes indicated (P = 0.022, Mann–Whitney test). (B)
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processing assay, we examined whether RNAs correspond-
ing to these regions could be processed by DROSHA.
Cell extracts were prepared from NIH/3T3 cells transiently
transfected with FLAG-tagged DROSHA and DGCR8
(Microprocessor, MP) (Figure 5E) before incubation with
in vitro transcribed RNA corresponding to the different
RNAs indicated in Figure 5D. Analysis of the size distri-
bution of RNAs by radiography in the presence of MP+
cell extracts revealed that compared toRNA incubatedwith
MP− cell extract, there was a loss of signal correspond-
ing to full-length hairpins and a concomitant appearance of
lower molecular weight RNA for all regions tested, indica-
tive of RNA processing (Figure 5F). Finally, the inclusion
of RNAs corresponding to these regions in in vitro DNA
methyltransferase assays resulted in a substantial reduction
in enzymatic activity (Figure 5G). Interestingly, we found
that RNAderived fromPdia4, a gene unaffected byDrosha-
deficiency, showed reduced ability to inhibit DNMT1 ac-
tivity (Supplementary Figure S16). According to RNA sec-
ondary structure prediction analysis, the RNAs analysed
are not predicted to be capable of forming stem–loop struc-
tures. However, the fact that they showed some inhibitory
activity on DNMT1 activity suggests the existence of addi-
tional mechanisms in vivo controlling which RNAs are ac-
cessible to both DNMT1 and DROSHA. Together, these
data indicate that putative hairpin regions within Cd97 and
Fbxo15 are capable of being processed by DROSHA and
that they can inhibit DNMT1 activity.
DISCUSSION
Holliday and Riggs originally proposed that the abil-
ity to recognize hemi-methylated DNA following semi-
conservative replication might be a sufficient mechanism
by which DNA methylation is stably inherited (36,37).
However, data accumulated since then have revealed the
existence of other mechanisms that are necessary to en-
sure the correct maintenance of methylation patterns.
These include the correct targeting of DNMT1 by the
chromatin-associated adaptor UHRFf1/NP95 (6,7) and
post-translational modifications controlling DNMT1 pro-
tein stability (8,9). More pertinent, a recent study revealed
that RNAs capable of adopting stem–loop structures are
capable of associating with and inhibiting DNMT1methyl-
transferase activity (14) and a recent description of the in-
teractome of the lncRNA Xist identified DNMT1 as a ma-
jor interacting factor (38).
Our results indicate that a major RNA-processing en-
zyme, DROSHA, is also capable of interacting with
DNMT1 and that DROSHA is necessary for full methyl-
transferase activity. It remains unclear if this interaction is
direct or indirect. Our IF studies indicate that for efficient
co-localization of the proteins to occur, the C-terminal re-
gion that contains a substantial portion of the RIIIDa, and
all of the RIIIDb and dsRBD is necessary. This obfuscates
attempts to determine whether the interaction is needed for
DROSHA to stimulate DNMT1 activity as deletion or mu-
tation analysis in this region is likely to have a significant
impact on DROSHA RNase activity. Another possibility
is that given that both proteins co-localize during S-phase,
this interaction may be necessary to help reduce local con-
centrations of inhibitory RNAs at the replication fork to
ensure full maintenance methylation activity.
The genomic hypomethylation that we observed in
Drosha-deficient ES cells occurs despite increased expres-
sion of the activeDNAmethyltransferases. The role ofmiR-
NAs in regulating Dnmt expression levels is controversial.
Two studies using the same Dicer−/− ES cell line reported
reduced expression of Dnmt3A and Dnmt3B, due to a loss
of expression of themir290-cluster and concomitant upreg-
ulation of Rbl mRNA, targeted by mir290 (29,31). In ad-
dition, the Benetti study also reported reduced expression
of DNMT1. Results from another group using a different
Dicer-deficient ES cell line concluded the cells had reduced
expression of DNMT3A and 3B (30). However, another re-
port using a third, different Dicer−/− ES cell line reported
no consistent difference in DNMT expression or RBL pro-
tein expression (39). Our results indicate differences in how
DROSHAandDICER controlDNMTexpression.We pro-
pose that a possible explanation for this discrepancy is that
DROSHA might act directly on Dnmt mRNA.
Recent data by several groups have documented that
naı¨ve ES cells (cultured in 2i media) are hypomethylated
relative to primed ES cells cultured in Fetal Bovine Serum
(FBS) (40–42). One possibility is that the hypomethylation
we observe is a consequence of Drosha-deficiency resulting
in cells being in the naı¨ve state, despite their culture in FBS.
We consider this unlikely because (i) cytosinemethylation in
naı¨ve ES cells is at a substantially lower level than the reduc-
tion we observe inDrosha-deficient cells and (ii) a hallmark
of the naı¨ve state is substantial downregulation of DNMT3
expression, which again is inconsistent with our protein and
mRNA expression data.
Our analysis of expression levels of TET1 and TET2 re-
vealed that while the former predominant species is un-
changed, TET2 levels are reduced in Drosha-deficient ES
cells. TET proteins are localized to specific regions of the
genome, particularly the promoters of genes associatedwith
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Volcano plot of log2 fold-change versus log10 P-value of 21 509 RefSeq genes inDrosha−/− compared to wild-type ES cells. Previously identified DNMT1
Interacting RNAs (DiRs) not upregulated in Dicer−/− microarray data highlighted in red, as well as Mir17hg and Dgcr8. (C) Bar graphs showing qRT-
PCR expression data of factors highlighted in (B). Results representative of two biological replicates. P-values (Mann–Whitney test) are: Pdia4, 0.4857
(wild-type versus Dicer−/−); Hspa5, 0.2, >0.99, 0.3429 (wild-type versus Drosha−-/−, wild-type versus Dicer−-/−, Drosha−/− versus Dicer−/−, respec-
tively). P = 0.028 for all other comparisons. All bar graphs show mean +/− standard deviation. Gapdh used for normalization. (D) Graphic showing
predicted hairpin/stem loop regions within Cd97 and Fbxo15 RNA. Numbers indicate base positions. (E) Western blot of lysate from HEK293T cells
transiently transfected with FLAG-tagged DROSHA and DGCR8 (+MP) probed with anti-FLAG antibody. –MP indicates material from untransfected
cells. (F) Autoradiograph of polyacrylamide gel-resolved in vitro transcribed RNAs indicated incubated with cell extracts from untransfected (–MP) or
Microprocessor transfected (+MP) cells. Note the great reduction in signal of unprocessed full-length RNA and appearance of lower molecular weight
smear in +MP lanes compared to –MP lanes. (G) Bar graph of in vitro methyltransferase assays. Cells were transfected with either DNMT1 alone or
DNMT1 along with the in vitro transcribed RNAs indicated.
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pluripotency as well as Polycomb-regulated loci (43,44).
As the hypomethylation caused by Drosha-deficiency is
genome-wide, combined with our analysis of TET1 and
TET2 expression this argues that TET-mediated demethy-
lation is unlikely to be involved.
Although most recognized for its role in miRNA biogen-
esis, DROSHA also has the ability to process other RNAs
containing stem–loop structures, such as mRNAs (22–25).
DiRs have only recently been reported and more work is re-
quired to determine their functional significance (14). We
note that DiRs were identified in human promyelocytic
cells (HL-60) and it is reasonable to assume that both cell-
type and species-specific differences in targets exist. We re-
port the identification of two transcripts, Fbxo15 andCd97,
which are upregulated specifically in Drosha-deficient ES
cells, which have also been previously reported as DiRs. We
find that regions within both transcripts predicted to form
stem–loop structures are processed by Microprocessor and
that these RNA regions are able to inhibit DNMT1 activity.
Whether DROSHA is able to process all DiRs is unknown.
Based on our genetic data indicating the involvement of
Drosha in regulating normal genomic levels of DNAmethy-
lation and that DROSHA is necessary for full DNMT1 ac-
tivity, we propose that DROSHA is required for the correct
processing of inhibitoryDiRs, thereby allowingDNMT1 to
achieve full methyltransferase activity.
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